X

Exagen
D

XGN

4.06000
USD
0.03
(0.74%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-4
Market Cap
71,607,349
News

Title: Exagen

Sector: Healthcare
Industry: Diagnostics & Research
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.